Answers are grounded in this paper and cite their sources.
Castration-resistant prostate cancer (CRPC) remains poorly controlled after sequential androgen receptor-targeted agents, taxanes, and radiopharmaceuticals. Tumor-tropic adipose-derived mesenchymal stem cells (ADSCs) offer a compelling platform for local delivery of gene-based therapeutics.This review synthesizes the mechanistic rationale, preclinical evidence, and translational strategy for hTERT-immortalized ADSCs engineered to express carboxylesterase (CE), secreted TRAIL (sTRAIL), or both, administered with irinotecan (CPT-11) in CRPC.We compared five studies from our group with independent work using mesenchymal stem cells, neural stem cells, and other carriers delivering CE-or TRAIL-based payloads, situating this platform within the broader field.Our studies used ubiquitin C promoter lentiviral vectors to express rabbit CE, rabbit CE2, human sTRAIL, or CE+sTRAIL.Efficacy was assessed mainly in subcutaneous PC3 xenografts and a PC3 tibial bone-metastasis model in male nude mice, using standardized migration, cytotoxicity, and apoptosis assays with in vivo tumor volume and osteolysis endpoints.Across all five studies, engineered ADSCs showed preferential tumor-tropic migration and localization after systemic delivery and consistently enhanced irinotecan efficacy at low prodrug doses, while becoming SN-38-sensitive themselves, providing built-in self-elimination.CE2, with superior CPT-11 hydrolytic efficiency over CE1, added anti-tumor potency and was active against bone-metastatic CRPC, including suppression of osteolysis.This program establishes a biologically coherent, iteratively refined platform for tumor-selective enzymeprodrug activation and death receptor-mediated apoptosis in CRPC.Translation requires resolving integrating-vector and hTERT immortalization safety concerns, quantitative biodistribution and persistence characterization, pharmacogenomics-informed irinotecan dosing, and immunogenicity assessment of xenogeneic CE.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: